Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Scarpi

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
European Radiology|February 9, 2018
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancerMichele Amadori, Domenico Barone, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2016
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
International Journal of Molecular Sciences|August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate CancerMaria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Tumori|June 4, 2026
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective studyMichela Palleschi, Filippo Merloni, Andrea Prochowski Iamurri, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology|August 6, 2020
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trialElisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
European Radiology|February 9, 2018
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancerMichele Amadori, Domenico Barone, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2016
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
International Journal of Molecular Sciences|August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate CancerMaria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Tumori|June 4, 2026
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective studyMichela Palleschi, Filippo Merloni, Andrea Prochowski Iamurri, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology|August 6, 2020
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trialElisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Pageof 22